3rd Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$795,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions. NO BILL, Tax Reform - Lobbied to gather information on potential legislation regarding deferral of foreign income.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: SENATE; Treasury, Dept of; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th)

Copyright/Patent/Trademark CPT

H.R. 1260 and S. 515, Patent Reform Act of 2009 - Lobbied to improve provisions related to inequitable conduct and damages. H.R. 706 and S. 369, Preserve Access to Affordable Generics Act - Lobbied to oppose banning patent settlements.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Health Resources & Services Administration (HRSA)

Bills named: H.R. 706 (111th), H.R. 1260 (111th), S. 369 (111th), S. 515 (111th)

Health Issues HCR

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; Treasury, Dept of; SENATE; Health Resources & Services Administration (HRSA)

Bills named: H.R. 1298 (111th), S. 1232 (111th), H.R. 1438 (111th), H.R. 3081 (111th), H.R. 3974 (111th), S. 525 (111th), H.R. 4899 (111th)

Medicare/Medicaid MMM

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Treasury, Dept of

Bills named: S. 254 (111th), H.R. 574 (111th), S. 565 (111th), H.R. 1485 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.